CN101358967A - 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 - Google Patents
一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 Download PDFInfo
- Publication number
- CN101358967A CN101358967A CNA200810118444XA CN200810118444A CN101358967A CN 101358967 A CN101358967 A CN 101358967A CN A200810118444X A CNA200810118444X A CN A200810118444XA CN 200810118444 A CN200810118444 A CN 200810118444A CN 101358967 A CN101358967 A CN 101358967A
- Authority
- CN
- China
- Prior art keywords
- chlorpromazine
- liquid
- kit
- haptens
- antiantibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 title claims abstract description 116
- 229960001076 chlorpromazine Drugs 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title claims abstract description 47
- 238000008157 ELISA kit Methods 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 109
- 102000004190 Enzymes Human genes 0.000 claims abstract description 75
- 108090000790 Enzymes Proteins 0.000 claims abstract description 75
- 238000001514 detection method Methods 0.000 claims abstract description 20
- 239000000243 solution Substances 0.000 claims description 39
- 239000000427 antigen Substances 0.000 claims description 37
- 102000036639 antigens Human genes 0.000 claims description 37
- 108091007433 antigens Proteins 0.000 claims description 37
- 239000011248 coating agent Substances 0.000 claims description 35
- 238000000576 coating method Methods 0.000 claims description 35
- 238000002372 labelling Methods 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 31
- 239000000872 buffer Substances 0.000 claims description 27
- 241001494479 Pecora Species 0.000 claims description 24
- 102000014914 Carrier Proteins Human genes 0.000 claims description 22
- 108010078791 Carrier Proteins Proteins 0.000 claims description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 239000012086 standard solution Substances 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- 210000002966 serum Anatomy 0.000 claims description 21
- 108010058846 Ovalbumin Proteins 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 20
- 229940092253 ovalbumin Drugs 0.000 claims description 20
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 18
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 17
- 239000007853 buffer solution Substances 0.000 claims description 17
- 239000000758 substrate Substances 0.000 claims description 17
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 16
- 210000004408 hybridoma Anatomy 0.000 claims description 14
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 13
- ZGUGWUXLJSTTMA-UHFFFAOYSA-N Promazinum Chemical compound C1=CC=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZGUGWUXLJSTTMA-UHFFFAOYSA-N 0.000 claims description 13
- 239000000460 chlorine Substances 0.000 claims description 13
- 229910052801 chlorine Inorganic materials 0.000 claims description 13
- 229960003598 promazine Drugs 0.000 claims description 13
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 13
- 229940033663 thimerosal Drugs 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 12
- 230000008878 coupling Effects 0.000 claims description 12
- 238000010168 coupling process Methods 0.000 claims description 12
- 238000005859 coupling reaction Methods 0.000 claims description 12
- 239000003550 marker Substances 0.000 claims description 12
- 238000004140 cleaning Methods 0.000 claims description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 9
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 8
- 230000001900 immune effect Effects 0.000 claims description 8
- 230000028327 secretion Effects 0.000 claims description 8
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 7
- 239000008363 phosphate buffer Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 239000003547 immunosorbent Substances 0.000 abstract 3
- 239000000523 sample Substances 0.000 description 41
- 238000002360 preparation method Methods 0.000 description 23
- 238000002965 ELISA Methods 0.000 description 22
- 239000012530 fluid Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 17
- 238000002835 absorbance Methods 0.000 description 10
- 241000287828 Gallus gallus Species 0.000 description 8
- 239000012488 sample solution Substances 0.000 description 8
- 238000004321 preservation Methods 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 229940098773 bovine serum albumin Drugs 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000008676 import Effects 0.000 description 5
- 235000015277 pork Nutrition 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
- 241000238557 Decapoda Species 0.000 description 4
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 229960002319 barbital Drugs 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- OTNVGWMVOULBFZ-UHFFFAOYSA-N sodium;hydrochloride Chemical compound [Na].Cl OTNVGWMVOULBFZ-UHFFFAOYSA-N 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- JDXQWYKOKYUQDN-UHFFFAOYSA-N 3-hydroxypyrrolidine-2,5-dione Chemical compound OC1CC(=O)NC1=O JDXQWYKOKYUQDN-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical class OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000143060 Americamysis bahia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100033195 DNA ligase 4 Human genes 0.000 description 1
- 235000016936 Dendrocalamus strictus Nutrition 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 101000927810 Homo sapiens DNA ligase 4 Proteins 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 244000118681 Iresine herbstii Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- -1 amino amino Chemical group 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
- 229950003616 azaperone Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108060003552 hemocyanin Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000010813 municipal solid waste Substances 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002990 phenothiazines Chemical class 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
药物名称 | 交叉反应率(%) |
氯丙嗪 | 100 |
异丙嗪 | 1 |
乙酰丙嗪 | <0.5 |
氟哌啶醇 | <0.1 |
阿扎哌隆 | <0.1 |
阿扎哌醇 | <0.5 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810118444XA CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810118444XA CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101358967A true CN101358967A (zh) | 2009-02-04 |
CN101358967B CN101358967B (zh) | 2012-07-25 |
Family
ID=40331471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810118444XA Expired - Fee Related CN101358967B (zh) | 2008-08-22 | 2008-08-22 | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101358967B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101987836A (zh) * | 2010-08-31 | 2011-03-23 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
CN102236012A (zh) * | 2010-04-21 | 2011-11-09 | 深圳出入境检验检疫局食品检验检疫技术中心 | 检测氯丙嗪的时间分辨荧光免疫分析试剂盒及其检测方法 |
CN102368072A (zh) * | 2011-06-30 | 2012-03-07 | 同昕生物技术(北京)有限公司 | 检测环孢霉素a药物浓度的化学发光酶联免疫检测试剂盒 |
CN103616506A (zh) * | 2013-12-11 | 2014-03-05 | 山东博科生物产业有限公司 | 一种酶标抗体试剂 |
CN104530239A (zh) * | 2014-12-26 | 2015-04-22 | 华中农业大学 | 用于检测吩噻嗪类药物的单克隆抗体及酶联免疫方法与试剂盒 |
CN107607721A (zh) * | 2017-09-16 | 2018-01-19 | 北京勤邦生物技术有限公司 | 一种氯丙嗪的磁免疫化学发光检测试剂盒及其应用 |
CN114410637A (zh) * | 2022-01-24 | 2022-04-29 | 江南大学 | 一种特异性结合氯丙嗪的核酸适配体的筛选及应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3976763A (en) * | 1975-04-30 | 1976-08-24 | Hoffmann-La Roche Inc. | Chlorpromazine assay |
US5512659A (en) * | 1989-08-04 | 1996-04-30 | Syntex (U.S.A.) Inc. | Compositions useful in heterogeneous immunoassays |
CN101236200B (zh) * | 2008-02-06 | 2012-09-05 | 中国计量学院 | 氯丙嗪的酶联免疫试剂盒及其检测方法 |
-
2008
- 2008-08-22 CN CN200810118444XA patent/CN101358967B/zh not_active Expired - Fee Related
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102236012A (zh) * | 2010-04-21 | 2011-11-09 | 深圳出入境检验检疫局食品检验检疫技术中心 | 检测氯丙嗪的时间分辨荧光免疫分析试剂盒及其检测方法 |
CN101987836A (zh) * | 2010-08-31 | 2011-03-23 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
CN101987836B (zh) * | 2010-08-31 | 2012-11-07 | 华南农业大学 | 氯丙嗪半抗原、人工抗原和抗体及其制备方法和应用 |
CN102368072A (zh) * | 2011-06-30 | 2012-03-07 | 同昕生物技术(北京)有限公司 | 检测环孢霉素a药物浓度的化学发光酶联免疫检测试剂盒 |
CN103616506A (zh) * | 2013-12-11 | 2014-03-05 | 山东博科生物产业有限公司 | 一种酶标抗体试剂 |
CN104530239A (zh) * | 2014-12-26 | 2015-04-22 | 华中农业大学 | 用于检测吩噻嗪类药物的单克隆抗体及酶联免疫方法与试剂盒 |
CN104530239B (zh) * | 2014-12-26 | 2017-12-05 | 华中农业大学 | 用于检测吩噻嗪类药物的单克隆抗体及酶联免疫方法与试剂盒 |
CN107607721A (zh) * | 2017-09-16 | 2018-01-19 | 北京勤邦生物技术有限公司 | 一种氯丙嗪的磁免疫化学发光检测试剂盒及其应用 |
CN107607721B (zh) * | 2017-09-16 | 2020-08-28 | 北京勤邦生物技术有限公司 | 一种氯丙嗪的磁免疫化学发光检测试剂盒及其应用 |
CN114410637A (zh) * | 2022-01-24 | 2022-04-29 | 江南大学 | 一种特异性结合氯丙嗪的核酸适配体的筛选及应用 |
CN114410637B (zh) * | 2022-01-24 | 2023-07-25 | 江南大学 | 一种特异性结合氯丙嗪的核酸适配体的筛选及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101358967B (zh) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101256188B (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN101013129B (zh) | 检测呋喃西林代谢物的酶联免疫试剂盒及其应用 | |
CN101413943B (zh) | 一种检测三聚氰胺的方法及其专用酶联免疫试剂盒 | |
CN101571539B (zh) | 检测头孢类药物的酶联免疫试剂盒及其应用 | |
CN101839918B (zh) | 一种检测螺旋霉素的方法及其专用酶联免疫试剂盒 | |
CN101358967B (zh) | 一种检测氯丙嗪的方法及其专用酶联免疫试剂盒 | |
CN101571541A (zh) | 检测磺胺类药物的酶联免疫试剂盒及其方法 | |
CN102080066B (zh) | 一种检测t-2毒素的方法及其专用试剂盒 | |
CN101021536B (zh) | 检测新霉素药物的酶联免疫试剂盒及方法 | |
CN101776685B (zh) | 检测三甲氧苄胺嘧啶药物的酶联免疫试剂盒及其应用 | |
CN101013130A (zh) | 检测呋喃它酮代谢物的酶联免疫试剂盒及其应用 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN101021535B (zh) | 检测庆大霉素药物的酶联免疫试剂盒及方法 | |
CN101358966B (zh) | 一种检测粘杆菌素的方法及其专用酶联免疫试剂盒 | |
CN101571540B (zh) | 检测猪免疫球蛋白g的酶联免疫试剂盒及其应用 | |
CN102967709A (zh) | 检测玉米赤霉烯酮药物的酶联免疫试剂盒及其应用 | |
CN101013131B (zh) | 呋喃妥因代谢物酶联免疫分析试剂盒及其应用 | |
CN102080067B (zh) | 一种检测呕吐毒素的方法及其专用试剂盒 | |
CN101349693A (zh) | 一种氟苯尼考类药物快速检测试剂盒及其应用 | |
CN101315378A (zh) | 检测硝基咪唑类药物的方法及其专用酶联免疫试剂盒 | |
CN101299046B (zh) | 一种检测红霉素类化合物的方法及其专用酶联免疫试剂盒 | |
CN100489530C (zh) | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 | |
CN101782579B (zh) | 检测泰妙菌素药物的酶联免疫试剂盒及其应用 | |
CN101526528A (zh) | 呋喃它酮代谢物检测试剂盒 | |
CN101299045A (zh) | 检测氟苯尼考及氟苯尼考胺的方法及其专用酶联免疫试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20120605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20120605 Address after: 102206 Beijing city Changping Huilongguan international information industry base, four High Street No. 8 Applicant after: Beijing Wanger Biotechnology Co.,Ltd. Address before: 102206 Beijing city Changping Huilongguan international information industry base, four High Street No. 8 Applicant before: Beijing Wanger Kangtai Biotechnology Co.,Ltd. Co-applicant before: Beijing Wanger Biotechnology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120725 Termination date: 20210822 |